Currently, several other B7 family ligands such as B7-H2 (a.k.a. inducible T cell costimulator ligand; ICOSL) and B7-H3 are being explored as novel immunotherapeutic targets in other cancer types (119). The gene discussed is ICOSLG; the disease is cancer.